Cargando…

Clinical Management of Squamous Cell Carcinoma of the Conjunctiva

Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Röck, Tobias, Bartz-Schmidt, Karl Ulrich, Bramkamp, Matthias, Milla, Jakob, Bösmüller, Hans-Christian, Röck, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011170/
https://www.ncbi.nlm.nih.gov/pubmed/32005796
http://dx.doi.org/10.12659/AJCR.919751
_version_ 1783496020036943872
author Röck, Tobias
Bartz-Schmidt, Karl Ulrich
Bramkamp, Matthias
Milla, Jakob
Bösmüller, Hans-Christian
Röck, Daniel
author_facet Röck, Tobias
Bartz-Schmidt, Karl Ulrich
Bramkamp, Matthias
Milla, Jakob
Bösmüller, Hans-Christian
Röck, Daniel
author_sort Röck, Tobias
collection PubMed
description Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinoma. A treatment with topical MMC was admistered Specialty: Ophthalmology OBJECTIVE: Rare disease BACKGROUND: Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface. This report illustrates the clinical management of squamous cell carcinoma of the conjunctiva. CASE REPORT: A 33-year-old female was referred to our eye hospital with a tumorous lesion on the nasal bulbar conjunctiva of the right eye. A topical therapy with antibiotic and corticosteroid eye drops did not change the lesion. The conjunctival tumor was widely resected. The histopathological diagnosis suggested a squamous cell carcinoma. After resection, a treatment with topical mitomycin C (MMC) 0.02% eye drops were started 4 times daily for 14 days. Two cycles of treatment were done with a 2-week interval during which only artificial tears eye drops were administered. At the 12-month follow-up, there was no sign of recurrence. CONCLUSIONS: This case illustrates the effective and successful clinical management of squamous cell carcinoma of the conjunctiva with excision and postoperative treatment with MMC 0.02% eye drops.
format Online
Article
Text
id pubmed-7011170
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-70111702020-02-24 Clinical Management of Squamous Cell Carcinoma of the Conjunctiva Röck, Tobias Bartz-Schmidt, Karl Ulrich Bramkamp, Matthias Milla, Jakob Bösmüller, Hans-Christian Röck, Daniel Am J Case Rep Articles Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinoma. A treatment with topical MMC was admistered Specialty: Ophthalmology OBJECTIVE: Rare disease BACKGROUND: Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface. This report illustrates the clinical management of squamous cell carcinoma of the conjunctiva. CASE REPORT: A 33-year-old female was referred to our eye hospital with a tumorous lesion on the nasal bulbar conjunctiva of the right eye. A topical therapy with antibiotic and corticosteroid eye drops did not change the lesion. The conjunctival tumor was widely resected. The histopathological diagnosis suggested a squamous cell carcinoma. After resection, a treatment with topical mitomycin C (MMC) 0.02% eye drops were started 4 times daily for 14 days. Two cycles of treatment were done with a 2-week interval during which only artificial tears eye drops were administered. At the 12-month follow-up, there was no sign of recurrence. CONCLUSIONS: This case illustrates the effective and successful clinical management of squamous cell carcinoma of the conjunctiva with excision and postoperative treatment with MMC 0.02% eye drops. International Scientific Literature, Inc. 2020-02-01 /pmc/articles/PMC7011170/ /pubmed/32005796 http://dx.doi.org/10.12659/AJCR.919751 Text en © Am J Case Rep, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Röck, Tobias
Bartz-Schmidt, Karl Ulrich
Bramkamp, Matthias
Milla, Jakob
Bösmüller, Hans-Christian
Röck, Daniel
Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title_full Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title_fullStr Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title_full_unstemmed Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title_short Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
title_sort clinical management of squamous cell carcinoma of the conjunctiva
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011170/
https://www.ncbi.nlm.nih.gov/pubmed/32005796
http://dx.doi.org/10.12659/AJCR.919751
work_keys_str_mv AT rocktobias clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva
AT bartzschmidtkarlulrich clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva
AT bramkampmatthias clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva
AT millajakob clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva
AT bosmullerhanschristian clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva
AT rockdaniel clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva